The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma - Concepedia

Concepedia

Publication | Open Access

The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma

DOI Full Paper Access

47

Citations

50

References

2021

Year

Rongrong Zhao, Boyan Li, Shouji Zhang, Zheng He, Ziwen Pan, Qindong Guo, Wei Qiu, Yanhua Qi, Shulin Zhao, Shaobo Wang,

Frontiers in Immunology

Abstract

Our results indicated that HSPA7 could be a novel immunotherapy target for GBM patients.

References

	Year	Citations

Page 1